Inducing postnatal expression of the Cdh23 gene in mice carrying the Cdh23tm2a mutant allele does not improve progressive hearing loss or restore stereocilia bundle structure, according to research conducted by Daniel R. Pentland and colleagues published in Scientific Reports. In characterising the mouse model, the investigators demonstrated that the Cdh23tm2a mutation causes reduced transcription of Cdh23, leading to early-onset progressive hearing loss in homozygous Cdh23tm2a/tm2a animals.
The Cdh23 gene encodes cadherin related 23, a structural protein essential for forming the tip links of stereocilia on sensory hair cells within the inner ear. In humans, mutations in CDH23 are linked to either non-syndromic deafness or Usher syndrome, whereas mutations in mouse Cdh23 produce hearing impairment with or without vestibular balance defects. Scanning electron microscopy of homozygous mutant mice confirmed pronounced architectural defects throughout the sensory stereocilia bundles.
The study also analysed heterozygous Cdh23+/tm2a mice, which exhibited progressive hearing loss restricted specifically to high sound frequencies. This high-frequency deficit was dependent on the co-occurrence of the Cdh23ahl allele present in the background C57BL/6N mouse strain. Despite this high-frequency functional impairment, scanning electron microscopy showed that stereocilia bundles in the heterozygous animals appeared structurally normal.
To test whether restoring Cdh23 transcription could rescue auditory function, the team excised the transcription disruption cassette within the Cdh23tm2a allele using tamoxifen-inducible Flp recombinase at either 4 days or 21 days after birth. Subsequent Auditory Brainstem Response threshold measurements and scanning electron microscopy examinations revealed no improvements in auditory sensitivity or stereocilia bundle organisation. The authors concluded that potential gene-directed therapies for Cdh23-associated hearing loss likely need to be administered very early in development, before sensory stereocilia bundles have fully matured.
The experimental characterisation of the Cdh23tm2a mouse model highlighted distinct phenotypic outcomes between homozygous and heterozygous animals. In Cdh23tm2a/tm2a homozygotes, reduced transcription of Cdh23 caused early-onset progressive hearing loss, alongside structural defects in stereocilia bundles revealed by scanning electron microscopy. In contrast, Cdh23+/tm2a heterozygotes exhibited progressive hearing loss that was restricted solely to high frequencies, and their stereocilia appeared normal under scanning electron microscopy. This high-frequency deficit in heterozygous mice was dependent on the Cdh23ahl allele present in the background C57BL/6N strain.
To test whether hearing loss could be reversed by restoring gene expression, the researchers removed the transcription disruption cassette within the Cdh23tm2a mutant allele using tamoxifen-inducible Flp recombinase. They induced this excision at either 4 days old or 21 days old. However, testing revealed no improvements in Auditory Brainstem Response thresholds or stereocilia bundle appearance after cassette removal at either timepoint.
These observations underscore the functional role of Cdh23, which encodes cadherin related 23, an essential component of the tip link of stereocilia on sensory hair cells in the inner ear. Mutations in human CDH23 result in either non-syndromic deafness or Usher syndrome, whereas mouse Cdh23 mutations lead to hearing impairment with or without balance defects. Because restoring postnatal expression failed to rescue auditory thresholds or bundle morphology, the authors noted that any treatments for Cdh23-associated hearing loss would probably need to be applied very early in development, before stereocilia are fully formed.
Subject of Research: Postnatal Cdh23 gene expression and progressive hearing loss in mouse models
Article Title: The Cdh23tm2a mouse allele causes progressive hearing loss that is not improved by postnatal Cdh23 gene expression
Article References: Pentland, D. R., Blackburn, J. W. D., Altiti, B., Ingham, N. J., Kirwin, D. A., & Steel, K. P. (2026). The Cdh23tm2a mouse allele causes progressive hearing loss that is not improved by postnatal Cdh23 gene expression. Scientific Reports. https://doi.org/10.1038/s41598-026-78429-x
Image Credits: AI Generated
DOI: 10.1038/s41598-026-78429-x
Keywords: Cdh23, cadherin related 23, stereocilia, sensory hair cells, progressive hearing loss, Cdh23tm2a, Auditory Brainstem Response, Flp recombinase, tamoxifen, Cdh23ahl, C57BL/6N, scanning electron microscopy, tip links, Usher syndrome, non-syndromic deafness, inner ear, gene expression
Cite Scienmag News
Juliet Wilcox. (November 18, 2026). Postnatal Cdh23 Expression Does Not Reverse Progressive Hearing Loss in Mice. Scienmag. https://scienmag.com/postnatal-cdh23-expression-does-not-reverse-progressive-hearing-loss-in-mice/
Juliet Wilcox. "Postnatal Cdh23 Expression Does Not Reverse Progressive Hearing Loss in Mice." Scienmag, 18 November 2026, https://scienmag.com/postnatal-cdh23-expression-does-not-reverse-progressive-hearing-loss-in-mice/. Accessed 18 November 2026.
Juliet Wilcox. "Postnatal Cdh23 Expression Does Not Reverse Progressive Hearing Loss in Mice." Scienmag. November 18, 2026. https://scienmag.com/postnatal-cdh23-expression-does-not-reverse-progressive-hearing-loss-in-mice/








